These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 5053206)

  • 21. Phenylketonuria, a family study. Borderline intelligence in two siblings with mentally retarded children.
    Colombo JP; Vassella F; Humbel R; Rossi E
    Helv Paediatr Acta; 1967 Jul; 22(3):243-51. PubMed ID: 5592735
    [No Abstract]   [Full Text] [Related]  

  • 22. [Phenylalanine level in the serum of heterozygotes for phenylketonuria under intensified protein catabolism].
    Bliumina MG
    Genetika; 1981; 17(5):910-4. PubMed ID: 7195856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterozygote detection in phenylketonuria.
    Güttler F; Hansen G
    Clin Genet; 1977 Feb; 11(2):137-46. PubMed ID: 837563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenylketonuria. Mass screening of newborns in Ireland.
    Cahalane SF
    Arch Dis Child; 1968 Apr; 43(228):141-4. PubMed ID: 5645686
    [No Abstract]   [Full Text] [Related]  

  • 25. About changes of the phenylalanine-tyrosine metabolism in psoriasis vulgaris.
    Knapp A
    Acta Univ Carol Med (Praha); 1986; 32(3-4):203-6. PubMed ID: 3434474
    [No Abstract]   [Full Text] [Related]  

  • 26. A new variant form of phenylketonuria.
    Watts RW; Purkiss P; Chalmers RA
    Q J Med; 1979 Jul; 48(191):403-17. PubMed ID: 317358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 50 years ago in the Journal of Pediatrics: identification of heterozygotes with phenylketonuria on basis of blood tyrosine responses.
    Ross LF
    J Pediatr; 2012 Sep; 161(3):487. PubMed ID: 22916975
    [No Abstract]   [Full Text] [Related]  

  • 28. Heterozygote detection in phenylketonuria. Measurement of discriminatory ability and interpretation of the phenylalanine loading test by determination of the heterozygote likelihood ratio.
    Westwood A; Raine DN
    J Med Genet; 1975 Dec; 12(4):327-33. PubMed ID: 1219115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Problems in the biochemical detection of heterozygotes for phenylketonuria.
    Yakymyshyn LY; Reid DW; Campbell DJ
    Clin Biochem; 1972 Mar; 5(1):73-81. PubMed ID: 5022449
    [No Abstract]   [Full Text] [Related]  

  • 30. [The validity of a screening test of heterozygotes for phenylketonuria].
    Giovannini M; Riva E; Stival G; Cividini D; Daroda C
    Minerva Pediatr; 1979 Nov; 31(21):1515-20. PubMed ID: 522842
    [No Abstract]   [Full Text] [Related]  

  • 31. Screening the "normal" population in Massachusetts for phenylketonuria.
    Levy HL; Karolkewicz V; Houghton SA; MacCready RA
    N Engl J Med; 1970 Jun; 282(26):1455-8. PubMed ID: 5419295
    [No Abstract]   [Full Text] [Related]  

  • 32. [Diagnostic and therapeutic problems of phenylketonuria. Parallel study of 2 familial cases as a function of treatment].
    Dhondt JL; Mesmacque-Caby D; Farriaux JP; Fontaine G
    Lille Med; 1972 Nov; 17(10):1432-6. PubMed ID: 4660861
    [No Abstract]   [Full Text] [Related]  

  • 33. Detection of phenylketonuria carriers.
    Kelly S; Rose F
    Public Health Rep (1896); 1969 Feb; 84(2):144-8. PubMed ID: 4980161
    [No Abstract]   [Full Text] [Related]  

  • 34. Detection of heterozygotes for phenylketonuria and hyperphenylaianinemia by gas-chromatographic analysis of aromatic acid excretion in urine.
    Koepp P; Hoffman B
    Clin Chim Acta; 1975 Feb; 58(3):215-21. PubMed ID: 1112063
    [No Abstract]   [Full Text] [Related]  

  • 35. The Guthrie screening test for phenylketonuria: a report on two years participation in the national programme.
    Becroft DM; Horn CR
    N Z Med J; 1969 Apr; 69(443):212-5. PubMed ID: 5254295
    [No Abstract]   [Full Text] [Related]  

  • 36. [Determination of heterozygote carrier state of phenylketonuria gene].
    D'iachkova AIa; Lebedev BV
    Pediatriia; 1969 Aug; 48(8):50-3. PubMed ID: 5354560
    [No Abstract]   [Full Text] [Related]  

  • 37. Intracellular concentrations of phenylalanine, tyrosine and alpha-aminobutyric acid in 13 homozygotes and 19 heterozygotes for phenylketonuria compared with 26 normals.
    Thalhammer O; Pollak A; Lubec G; Königshofer H
    J Inherit Metab Dis; 1981; 4(2):73-4. PubMed ID: 6790854
    [No Abstract]   [Full Text] [Related]  

  • 38. Intracellular concentrations of phenylalanine, tyrosine and alpha-aminobutyric acid in 13 homozygotes and 19 heterozygotes for phenylketonuria (PKU) compared with 26 normals.
    Thalhammer O; Pollak A; Lubec G; Königshofer H
    Hum Genet; 1980; 54(2):213-6. PubMed ID: 7390492
    [No Abstract]   [Full Text] [Related]  

  • 39. Phenylalanine loading and aromatic acid excretion in normal subjects and heterozygotes for phenylketonuria.
    Blau K; Summer GK; Newsome HC; Edwards CH
    Clin Chim Acta; 1973 May; 45(3):197-205. PubMed ID: 4708049
    [No Abstract]   [Full Text] [Related]  

  • 40. Detection of heterozygotes for phenylketonuria by constant intravenous infusion of L-phenylalanine.
    Jagenburg R; Rödjer S
    Clin Chem; 1977 Sep; 23(9):1661-5. PubMed ID: 890910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.